ABSTRACT
As a call to action in the field, we highlight that the COVID-19 pandemic is an abrupt and chronic stressor to children and families of disadvantaged and marginalized backgrounds. Critically, this global crisis has a disproportionate impact on the physical, mental and behavioral health of these vulnerable members of society, due to pre-existing disadvantages such as economic hardship, educational inequities, risks of maltreatment and community violence. A lack of access to mental health support further deprives children and their caregivers of the resources needed to cope with magnified adversities during the pandemic. We believe these inequalities are not the mere result of the pandemic, but enduring issues in society that are detrimental to the wellbeing of the most vulnerable. We advocate for long-term strategies to change societal structures that oppress marginalized children and families, and believe the pandemic reflects a pressing need to invest in interventions.
Subject(s)
COVID-19 , Intellectual DisabilityABSTRACT
COVID-19 presents significant social, economic, and medical challenges. Because COVID-19 has already begun to precipitate huge increases in mental health problems, clinical psychological science must assert a leadership role in guiding a national response to this secondary crisis. In this paper, COVID-19 is conceptualized as a unique, compounding, multi-dimensional stressor that will create a vast need for intervention and necessitate new paradigms for mental health service delivery and training. Urgent challenge areas across developmental periods are discussed, followed by a review of psychological symptoms that likely will increase in prevalence and require innovative solutions in both science and practice. Implications for new research directions, clinical approaches, and policy issues are discussed to highlight the opportunities for clinical psychological science to emerge as an updated, contemporary field capable of addressing the burden of mental illness and distress in the wake of COVID-19 and beyond.